Ivan Alexandrovich Sadkovskii

Mr. Ivan Alexandrovich Sadkovskii

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LKLiudmila A. Korol
Liudmila A. Korol
SESvetlana N. Egorova
Svetlana N. Egorova
DKDmitry Kudlay
Dmitry Kudlay
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
SSSusanna Sergeevna Sologova
Susanna Sergeevna Sologova
КАКудлай Дмитрий Анатольевич
Кудлай Дмитрий Анатольевич
Age-associated disorders, including cognitive functions, that often occur in geriatric patients, necessitate the use of novel approaches to provide appropriate medical care, pharmacoprophylaxis and pharmacotherapy among them. At the same time, an important objective of the national healthcare system is not only stimulating of pharmaceutical companies and pharmacies to expand the range of medicines intended for elderly patients, but also increasing availability of medicinal products, including the integration of extemporaneous formulations into clinical practice. Presented review considers several features of the regulation of the use of extemporaneous formulations in the treatment of geriatric patients. Examples of prescriptions that are used in Russian medical practice and are of the greatest interest in the treatment of elderly patients are also presented.

28 August 2024 in Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
ЛКЛ. А. Король
Л. А. Король
SES. N. Egorova
S. N. Egorova
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ABA. V. Bykov
A. V. Bykov
INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency.

28 May 2025 in Drug development & registration
Verified
Journal Article
Open access
PDF file
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
ЛКЛ. А. Король
Л. А. Король
AKA. B. Karabanova
A. B. Karabanova
AKA. V. Korolenko
A. V. Korolenko
ESE. A. Shemetova
E. A. Shemetova
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
Introduction. Adhesive baseplates, designed to fix ostomy bags and protect the skin of the peristomal area of ostomy patients, are a key element of an ostomy bag or urine bag. The functionality of adhesive baseplates is ensured by a set of their technical characteristics and design features, which makes the choice of appropriate baseplate testing methods an important aspect in the development, production and quality control of these medical devices.Text. For testing adhesive baseplates, methods provided by Russian and international standards, as well as those not included in them, can be used. The methods provided by the standards include description of appearance (size), testing of adhesive strength, study of surface pH, as well as tests for wet integrity and water absorbancy. Methods not included in the standards for adhesive plates, but widely described in the scientific literature and used by researchers in practice include testing of some adhesive and mechanical properties, such as tack, shear strength, as well as tensile or bending tests to characterize the strength and deformation properties of the baseplate material. In addition, for adhesive baseplates, methods for testing medical properties common to all medical devices that are exposed to skin can be used. Besides this, it is shown how the adhesive properties of baseplates can be predicted based on the rheological properties of the adhesive layer, and factors important in the selection of materials modeling skin for in vitro tests are described.Conclusion. The review presents a detailed description of methods of interest for testing adhesive baseplates, in particular their general principles and conditions of implementation, as well as methods that allow predicting the adhesive properties of plates and determining the relationship between adhesion tests in vivo and in vitro. A number of the described methods are of interest to include in normative documentation for adhesive baseplates tests, subject to their unification and modification taking into account the characteristics of this medical device.

9 August 2024 in Drug development & registration
Verified
Journal Article
Open access
PDF file
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
EPElizaveta Dmitrievna Pinegina
Elizaveta Dmitrievna Pinegina
ЛКЛ. А. Король
Л. А. Король
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
Introduction. Darunavir as an effective antiretroviral drug is widely used in clinical practice, including for the treatment of pediatric patients, as well as pregnant women, and for personalized therapy. Currently darunavir is used in the production of finished dosage forms, both in the form of crystalline ethanolate and in the form of an amorphous substance. In this regard, there is a need to develop and improve methods for the quantitative determination of darunavir. As an inexpensive and effective alternative to common chromatographic and titrimetric methods, spectrophotometric determination of darunavir in the ultraviolet region of the spectrum (UV spectrophotometry) may be used.Aim. To develop and validate a method for the quantitative determination of amorphous darunavir in the substance by UV spectrophotometry.Materials and methods. The following substances and consumables were used for the research: powdered amorphous darunavir substance (USP); darunavir reference standard (MSN Pharmachem Pvt. Ltd., India); methanol for HPLC Gradient Grade 99.9 % (High purity); acetonitrile for HPLC Gradient Grade 99.9 %; glacial acetic acid for HPLC; 0.1 M perchloric acid solution (in anhydrous acetic acid) for titration in non-aqueous media; nylon syringe filters with a pore diameter of 0.22 microns. Spectrophotometric determination of darunavir was carried out using an Cary 60 spectrophotometer (Agilent Technologies, USA) and a UNICO 2800 spectrophotometer (United Products & Instruments, Inc., USA). To prepare standard solutions, we used analytical balance Analytical Balance MS105/A (METTLER TOLEDO, Switzerland), analytical balance GH-120 (AND, Japan) class A measuring glassware, graduated pipettes ISOLAB.Results and discussion. The method was developed and validated for the following characteristics: specificity, linearity, accuracy, precision, analytical range. According to the study results, the main validation characteristics of the method meet the acceptance criteria.Conclusion. A new method for the quantitative determination of amorphous darunavir by UV spectrophotometry was successfully developed and validated. The method may be used to control the quality of substances of amorphous darunavir, including the intrapharmaceutical control.

28 May 2025 in Drug development & registration
Verified
Journal Article
Open access
PDF file
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
SASabr Alikhanovich Albagachiev
Sabr Alikhanovich Albagachiev
ЛКЛ. А. Король
Л. А. Король
ESE. A. Shemetova
E. A. Shemetova
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
Introduction. Polymer compositions, which are the basis of most dosage forms intended for application to the skin, including transdermal patches, determine both the biopharmaceutical properties of the drug and the consumer properties of the dosage form. Consumer properties are important for the patient. They determine the patient's commitment not only to therapy, but also to a specific manufacturer. Adhesive plates of colostomy bags are used for fixing ostomy bags and protecting the skin of the peristomal area. They are characterized by a set of consumer properties that determine their quality and may be a good model for studying the influence of consumer properties on patient preferences.Aim. Development of comparative analysis method of adhesive plates polymer compositions based on consumer properties.Materials and methods. To achieve the research goal, a set of methods was used, including bibliographic, analytical, comparative, survey and structural-functional analysis. To determine the weighting coefficients of various consumer characteristics of adhesive plates, a survey of experts was conducted.Results and discussion. The main consumer properties of adhesive plates of ostomy pouches have been determined, which include: no adhesive residue on the skin after removal, ease of removal, wearing time, flexibility, ease of use, resistance to moisture and secretions, comfort of use, adhesion, strength of adhesion to the skin, prevention of leakage and no peristomal complications. Based on expert evaluation, weighting coefficients for each consumer property were determined, and a methodology for comparative evaluation of adhesive plates of ostomy pouches was proposed. The methodology can be used for comparative analysis of adhesive plates from different manufacturers.Conclusion. A methodology for the comparative evaluation of ostomy pouches was successfully developed. It can be used as a basis for developing a similar methodology for evaluating skin-applied dosage forms based on their consumer properties.

27 August 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
VMVeronika Viktorovna Makarova
Veronika Viktorovna Makarova
LKLudmila Korol
Ludmila Korol
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
SASegrey Antonov
Segrey Antonov
Background: Hot-melt extrusion (HME) is a scalable pharmaceutical technology increasingly relevant to flexible manufacturing, including small-batch production, personalized dosage-form development, and potential use in pharmacy compounding. When translated into compounding practice, however, HME introduces a risk that routine quality-control methods available in pharmacies may be insufficient to reliably assess the stability of extrusion-based preparations. Methods: Granules containing 50% (w/w) darunavir were prepared by HME at 70 and 90 °C using a previously developed polymeric premix. Samples were stored for 24 months under ambient conditions. During storage, routine quality attributes were evaluated, including appearance, particle size distribution, loss on drying, disintegration time, content uniformity, and assay. Solid-state changes were investigated using differential scanning calorimetry (DSC) and X-ray diffraction (XRD), with a reference PEG-associated darunavir sample prepared and characterized for comparative analysis. Changes in drug release and darunavir content were assessed by dissolution testing and HPLC analysis, respectively. Results: Granules produced at both extrusion temperatures retained acceptable routine quality attributes throughout the 24-month storage period. No substantial changes were detected by visual inspection, pharmacopoeial tests, or UV assay. However, DSC revealed a new thermal event after storage, while XRD showed the formation of a new crystalline phase. Comparison with the reference PEG-associated sample supported the assignment of this phase as a PEG-associated crystalline phase of darunavir. Importantly, this transformation occurred even though the routine quality attributes evaluated in pharmacy compounding practice remained unchanged. Dissolution profiles differed between samples tested immediately after preparation and after long-term storage, with a more pronounced overall difference for granules produced at 90 °C, whereas HPLC confirmed comparable darunavir content in all investigated samples. Discussion: Our results show that routine compounding quality control can meet conventional acceptance criteria while failing to detect API solid-state changes in the investigated HME-derived system. In the PEG-containing matrix, amorphous darunavir undergoes storage-induced crystallization, forming a PEG-associated crystalline phase consistent with its known affinity for polyol-containing media. Conclusions: Acceptable routine quality attributes do not necessarily reflect the solid-state stability of APIs in HME-based formulations. These results highlight the need for solid-state risk assessment when developing extrusion-based systems intended for pharmacy compounding and other personalized manufacturing models in which routine quality control may not include advanced solid-state characterization.